WCM Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-286,527
| Closed | -$4.5M | – | 289 |
|
|
2024
Q3 | $4.5M | Sell |
286,527
-2,890
| -1% | -$45.3K | 0.01% | 169 |
|
|
2024
Q2 | $4.74M | Buy |
289,417
+7,382
| +3% | +$121K | 0.01% | 164 |
|
|
2024
Q1 | $5.21M | Buy |
+282,035
| New | +$5.21M | 0.01% | 160 |
|
|
2021
Q2 | – | Sell |
-129,864
| Closed | -$3.35M | – | 196 |
|
|
2021
Q1 | $3.35M | Buy |
129,864
+56,330
| +77% | +$1.45M | 0.01% | 145 |
|
|
2020
Q4 | $3.93M | Buy |
73,534
+415
| +0.6% | +$22.2K | 0.01% | 148 |
|
|
2020
Q3 | $3.02M | Buy |
73,119
+3,349
| +5% | +$138K | 0.01% | 150 |
|
|
2020
Q2 | $3.38M | Sell |
69,770
-27,891
| -29% | -$1.35M | 0.01% | 143 |
|
|
2020
Q1 | $4.13M | Buy |
97,661
+28,235
| +41% | +$1.19M | 0.02% | 120 |
|
|
2019
Q4 | $2.97M | Buy |
69,426
+56,750
| +448% | +$2.43M | 0.02% | 137 |
|
|
2019
Q3 | $456K | Buy |
+12,676
| New | +$456K | ﹤0.01% | 144 |
|